James Day, Business Executive for Securities Finance, EMEA, BNY Mellon, and Charles Morris, Senior Associate, Clifford Chance, hosted a call on the impact of the Securities Financing Transactions Regulation (SFTR).
The update was hosted by Bill Kelly, Global Head of Client Management & Business Development, Securities Finance, BNY Mellon. The speakers were Mike McAuley, Global Head of Product Strategy, Securities Finance, BNY Mellon and Eli Peterson, Managing Director, Office of Public Policy and Regulatory Affairs, BNY Mellon.
Regulators around the globe are focusing on systemic risk and financial stability across firms, products and services. In the past, regulators would review these firms, products and services individually, and regulations were aimed at preserving safety and soundness at a micro level. With today’s more comprehensive approach, regulators are looking at the size, complexity and interconnectivity of firms, products and services and how together they can contribute to systemic risk.
To help preserve financial stability and mitigate systemic risk, regulators are introducing new requirements with two main objectives.
Regulators around the globe are pursuing these objectives, but it is not necessarily a coordinated effort.
When reviewing the new regulations, it is also important to consider the issue of parity among the different types of transactions. It could be argued that under recent regulations derivatives are receiving preferential treatment compared to securities financing transactions. This may largely reflect the regulators’ strong focus on derivatives directly after the 2008 financial crisis.
Overall, the current regulatory climate is complex. Regulations are changing the securities finance marketplace and affecting the way borrowers, agent lenders and beneficial owners behave and interact. Understanding these changes is a difficult task but an important one.
The SLR is having a significant impact on securities finance. This measure is a ratio of an institution’s capital to its assets, and it is having the greatest effect on the borrowers in a securities lending transaction. As borrowers look to manage their balance sheet in line with SLR requirements, they are increasingly interested in posting non-cash collateral in securities lending transactions. In addition they have also reduced their level of participation in the repo market which impacts the ability to invest cash collateral.
The SLR is also driving conversations around the development of a buy-side friendly model for the central clearing of agency securities lending and repo transactions. A CCP clearing model would allow borrowers some benefits of accounting netting (i.e., offsetting cash payables with cash receivables) which potentially permits them to engage in a higher volume of transactions without negatively impacting their balance sheet. This could become another distribution channel for client securities.
The ratio is also being implemented in Europe, but in the U.S., the required ratio is higher. There have been some discussions and proposals on increasing the leverage requirement for certain institutions in Europe.
The LCR measures a firm’s short-term liquidity by comparing its high quality liquid assets (HQLA) to its net outflows over a 30-day stress period. For securities finance, the result is that borrowers are increasingly interested in term or evergreen securities lending transactions which are longer than 30 days. In addition, the LCR has created demand for collateral upgrade trades in which firms use non-HQLA or excess HQLA as collateral in order to borrow required HQLA.
The Collins Amendment establishes a floor requiring certain large U.S. bank holding companies to calculate risk weighted assets under both standardized and advanced approaches and meet minimum capital requirements under both approaches. Non-U.S. institutions are not subject to the Collins Amendment.
The standardized and advanced approaches treat securities financing transactions differently. The standardized approach applies market and currency haircuts to the securities loaned and collateral received to determine the exposure amount of the transaction. The advanced approach provides more risk-sensitive calculations. Due to the Collins Amendment, financial institutions must follow the approach that produces the lower ratio.
In addition, different lenders (e.g., bank, non-bank) have different risk weights. To the extent that borrowers can transact with a lender that has a lower risk weight, such a transaction results in a lower risk-weight asset number. As a result, prior to a transaction taking place, borrowers are increasingly interested in knowing the participating lenders and are expressing preferences for certain types of lenders. This may lead to bifurcated pricing based on a lender’s risk weight.
Single counterparty credit limits, recently re-proposed in the U.S., could have a significant impact on large agent lenders and in turn, their beneficial owner clients. The indemnification that an agent lender provides to its underlying client is treated under these proposed rules as a credit exposure of the agent lender to the borrower. Further, the agent lender’s total exposure to any institution would include all affiliates and associated companies. The exposure limit for a global systemically important bank (G-SIB) to a non-G-SIB is twenty-five percent of tier 1 capital, but when a G-SIB deals with another G-SIB, that limit goes down to fifteen percent of tier 1 capital. G-SIBs include several agent lenders and most of the top borrowers in lending programs. So, as the large agent lenders near this fifteen percent limit, there could be capacity constraints on their ability to provide indemnification.
The comment period for the proposed U.S. rules has just been completed, and there are advocacy efforts underway to seek a more risk-sensitive methodology for calculating exposures under securities financing transactions similar to the one that Basel has proposed. In addition, the U.S. proposal seems to indicate that derivatives might receive a better treatment than securities finance transactions which could create regulatory arbitrage between the two types of transactions.
The NSFR is a longer term liquidity measure of a firm’s available stable funding over its required stable funding. For securities financing transactions, this ratio will require borrowers to raise long-term funding for a portion of a short-term securities financing transaction which will significantly add to the cost of that transaction. For example, the borrower has a hedge fund client which is shorting securities. The borrower will lend these securities to the hedge fund, and the hedge fund will give the borrower the cash proceeds from the short sale. This cash will be the borrower’s available stable funding. The borrower will then pass that cash to the agent lender as collateral for borrowing the security. That cash (asset) will then have a required stable funding requirement. The credit that the borrower receives for the available stable funding of the cash that’s given to them by the hedge fund is smaller than the required stable funding they need for the cash provided as collateral. This mismatch will significantly add to the cost of that transaction and may create further incentive for the increased use of non-cash collateral in securities financing transactions.
The FSB workstream on securities lending and repo issued a series of recommendations covering collateral reuse, transparency, minimum haircuts and reinvestment of cash collateral. These recommendations have driven individual regulations across different jurisdictions. For example, Basel issued a proposal that integrated minimum haircuts for non-centrally cleared securities finance transactions into the capital rules. Not complying with these minimum haircut requirements will result in an unsecured exposure which is detrimental from a capital perspective.
The transparency recommendation has also given rise to additional regulations including the securities financing transaction reporting legislation in Europe. The Securities Financing Transactions Regulation (SFTR) will require the reporting of securities finance and repo transactions. In addition, when collateral in a securities finance transaction is taken under a transfer of title arrangement, the collateral receiver will have to provide notification of its intent with respect to the reuse of this collateral. The same notification may also apply to repurchase agreements in cash collateral reinvestment programs because that is also under a transfer of title arrangement.
As different jurisdictions roll out these transparency rules, clients and their agents may have to deal with duplicate reporting requirements.
In Europe, regulators are attempting to segregate alternative investment fund (AIF) assets from other assets held by depositories and custodians. For securities finance transactions, the issue is whether this segregation is required at the subcustodial level. Currently, custodians utilize omnibus accounts with most subcustodians to hold assets in a local jurisdiction. These assets are allocated out to individual clients by means of books and records. If asset segregation is required at the subcustodian level, then individual accounts would be required for each AIF which would make securities lending more difficult for these funds. These individual accounts would increase the cost of securities financing transactions placing AIFs at a distinct disadvantage. AIFMD would have an impact on AIFs and their ability to engage and earn revenue in a securities lending program. This could also apply to UCITS funds.
Unlike the U.S. rules and some of the jurisdictional rules, the European CSDR specifically includes securities lending and repurchase transactions in its proposed buy-in rules. This European regulation initiates mandatory buy-ins for failing transactions.
The CSDR does exempt short-term transactions, so many securities finance transactions would not fall under this regulation. However, the increasingly popular term/evergreen securities financing transactions would be subject to CSDR buy-in requirements.
These regulations will require counterparties who transact with G-SIBs to agree to adhere to a document under which they agree to be bound by applicable jurisdictional stays on the exercise of termination rights and cross default rights. While lenders and agents will have some operational and administrative requirements, this should have a positive impact overall. If a G-SIB defaults, the regulators will likely come in at the holding company level allowing the operating subsidiaries to remain solvent. This will most likely result in an orderly unwind of securities finance transactions in which securities will be returned to the operating subsidiary and then back to the agent lenders.
U.S. proposed rules apply to U.S. law contracts with U.S. counterparties unlike other jurisdictions that apply only to contracts governed by third-party law.
As it’s currently proposed, the European FTT includes securities lending and repo transactions, and this proposal will have an extra-territorial reach and could affect transactions outside the member states on a global scale. Under the FTT, there will be the potential for increased transaction costs for borrowers and potential increased reporting, withholding and payment requirements for agent lenders. For beneficial owners, there could be reduced demand for securities lending and hence fewer revenue opportunities. There has not been much activity around the FTT in recent months, however, the debate continues.
The relationship between regulation and securities finance is complex and continues to change. Some rules have been finalized, but regulators are returning to them to calibrate certain details or refine calculations. Other regulations have yet to be fully implemented and jurisdictional differences can complicate this implementation. How this relationship evolves will have a significant impact on the financial marketplace and will continue to be a major topic of discussion in years to come.
The views expressed in this Roundtable are solely those of the Roundtable participants, and do not represent the views of their employers, or its representatives. The material is for general information purposes only and is not intended to provide or be construed as legal, tax, accounting, investment, financial or other professional advice on any matter.
BNY Mellon is the corporate brand of The Bank of New York Mellon Corporation and may be used as a generic term to reference the corporation as a whole and/or its various subsidiaries generally. This material and any products and services may be issued or provided under various brand names in various countries by duly authorized and regulated subsidiaries, affiliates, and joint ventures of BNY Mellon, which may include any of the following. The Bank of New York Mellon, at 225 Liberty St, NY, NY USA, 10286, a banking corporation organized pursuant to the laws of the State of New York, and operating in England through its branch at One Canada Square, London E14 5AL, UK, registered in England and Wales with numbers FC005522 and BR000818. The Bank of New York Mellon is supervised and regulated by the New York State Department of Financial Services and the U.S. Federal Reserve and authorized by the Prudential Regulation Authority. The Bank of New York Mellon, London Branch is subject to regulation by the Financial Conduct Authority and limited regulation by the Prudential Regulation Authority. Details about the extent of our regulation by the Prudential Regulation Authority are available from us on request. The Bank of New York Mellon SA/NV, a Belgian public limited liability company, with company number 0806.743.159, whose registered office is at 46 Rue Montoyerstraat, B-1000 Brussels, Belgium, authorized and regulated as a significant credit institution by the European Central Bank (ECB), under the prudential supervision of the National Bank of Belgium (NBB) and under the supervision of the Belgian Financial Services and Markets Authority (FSMA) for conduct of business rules, and a subsidiary of The Bank of New York Mellon. The Bank of New York Mellon SA/NV operates in England through its branch at 160 Queen Victoria Street, London EC4V 4LA, UK, registered in England and Wales with numbers FC029379 and BR014361. The Bank of New York Mellon SA/NV (London Branch) is authorized by the ECB and subject to limited regulation by the Financial Conduct Authority and the Prudential Regulation Authority. Details about the extent of our regulation by the Financial Conduct Authority and Prudential Regulation Authority are available from us on request The Bank of New York Mellon SA/NV operating in Ireland through its branch at 4th Floor Hanover Building, Windmill Lane, Dublin 2, Ireland trading as The Bank of New York Mellon SA/NV, Dublin Branch, is authorized by the ECB and is registered with the Companies Registration Office in Ireland No. 907126 & with VAT No. IE 9578054E. The Bank of New York Mellon, Singapore Branch, subject to regulation by the Monetary Authority of Singapore. The Bank of New York Mellon, Hong Kong Branch, subject to regulation by the Hong Kong Monetary Authority and the Securities & Futures Commission of Hong Kong. If this material is distributed in Japan, it is distributed by The Bank of New York Mellon Securities Company Japan Ltd, as intermediary for The Bank of New York Mellon. Not all products and services are offered in all countries.
The information contained in this material is intended for use by wholesale/professional clients or the equivalent only and is not intended for use by retail clients. If distributed in the UK, this material is a financial promotion.
This material, which may be considered advertising, is for general information purposes only and is not intended to provide legal, tax, accounting, investment, financial or other professional advice on any matter. This material does not constitute a recommendation by BNY Mellon of any kind. Use of our products and services is subject to various regulations and regulatory oversight. You should discuss this material with appropriate advisors in the context of your circumstances before acting in any manner on this material or agreeing to use any of the referenced products or services and make your own independent assessment (based on such advice) as to whether the referenced products or services are appropriate or suitable for you. This material may not be comprehensive or up to date and there is no undertaking as to the accuracy, timeliness, completeness or fitness for a particular purpose of information given. BNY Mellon will not be responsible for updating any information contained within this material and opinions and information contained herein are subject to change without notice. BNY Mellon assumes no direct or consequential liability for any errors in or reliance upon this material.
This material may not be distributed or used for the purpose of providing any referenced products or services or making any offers or solicitations in any jurisdiction or in any circumstances in which such products, services, offers or solicitations are unlawful or not authorized, or where there would be, by virtue of such distribution, new or additional registration requirements.
Neither BNY Mellon nor any of its respective officers, employees or agents are, by virtue of providing the materials or information contained herein, acting as an adviser to any recipient (including a “municipal advisor” within the meaning of Section 15B of the Securities Exchange Act of 1934, as amended, “Section 15B”), do not owe a fiduciary duty to the recipient hereof pursuant to Section 15B or otherwise, and are acting only for their own interests.
All references to dollars are in U.S. dollars unless specified otherwise.
This material may not be reproduced or disseminated in any form without the prior written permission of BNY Mellon. Trademarks, logos and other intellectual property marks belong to their respective owners.
The Bank of New York Mellon, member FDIC.
© 2016 The Bank of New York Mellon Corporation. All rights reserved.
Managing Director & Business Executive for Securities Finance in EMEA
BNY Mellon Markets
James is a Managing Director of BNY Mellon and Business Executive for Securities Finance in EMEA for BNY Mellon Markets, which includes Securities Lending.View Profile